Generics in South Africa

Generics in South Africa

Code: ML-OHME4690 | Published: Jan-2016 | Pages: 36 | MarketLine
Price :
$350.00
USD

* Required Fields

$350.00

Details

Generics in South Africa industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the South Africa generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

- For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the generic-eligible market, are not included.

- The South African generics market is expected to generate total revenues of $729m in 2015, representing a compound annual growth rate (CAGR) of 9% between 2011 and 2015.

- Market consumption volume is forecast to reach a total of 76.3% of total pharma volume in 2015.

- The government is showing strong support for generic drugs in Africa, which should see good growth in the future. For example, pharmacists are required by law to inform private patients about generic alternatives.

Key Findings
Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in South Africa

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in South Africa

Leading company profiles reveal details of key generics market players global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the South Africa generics market with five year forecasts by both value and volume

Macroeconomic indicators provide insight into general trends within the South Africa economy

Reasons To Buy
What was the size of the South Africa generics market by value in 2015?

What will be the size of the South Africa generics market in 2020?

What factors are affecting the strength of competition in the South Africa generics market?

How has the market performed over the last five years?

How large is South Africas generics market in relation to its regional counterparts?

Table of Contents

TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Market volume 2
Market volume forecast 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 9
Market value 9
Market volume 10
Market Segmentation 11
Geography segmentation 11
Market Outlook 12
Market value forecast 12
Market volume forecast 13
Five Forces Analysis 14
Summary 14
Buyer power 15
Supplier power 16
New entrants 17
Threat of substitutes 18
Degree of rivalry 19
Leading Companies 20
Adcock Ingram Holdings Limited 20
Aspen Pharmacare Holdings Ltd 24
Teva Pharmaceutical Industries Limited 28
Macroeconomic Indicators 31
Country Data 31
Methodology 33
Industry associations 34
Related MarketLine research 34
Appendix 35
About MarketLine 35

List of Tables
Table 1: South Africa generics market value: $ million, 2011-15(e)
Table 2: South Africa generics market volume: % of total pharma volume, 2011-15(e)
Table 3: South Africa generics market geography segmentation: $ billion, 2015(e)
Table 4: South Africa generics market value forecast: $ million, 2015-20
Table 5: South Africa generics market volume forecast: % of total pharma volume, 2015-20
Table 6: Adcock Ingram Holdings Limited: key facts
Table 7: Adcock Ingram Holdings Limited: key financials ($)
Table 8: Adcock Ingram Holdings Limited: key financials (ZAR)
Table 9: Adcock Ingram Holdings Limited: key financial ratios
Table 10: Aspen Pharmacare Holdings Ltd: key facts
Table 11: Aspen Pharmacare Holdings Ltd: key financials ($)
Table 12: Aspen Pharmacare Holdings Ltd: key financials (ZAR)
Table 13: Aspen Pharmacare Holdings Ltd: key financial ratios
Table 14: Teva Pharmaceutical Industries Limited: key facts
Table 15: Teva Pharmaceutical Industries Limited: key financials ($)
Table 16: Teva Pharmaceutical Industries Limited: key financial ratios
Table 17: South Africa size of population (million), 2011-15
Table 18: South Africa gdp (constant 2005 prices, $ billion), 2011-15
Table 19: South Africa gdp (current prices, $ billion), 2011-15
Table 20: South Africa inflation, 2011-15
Table 21: South Africa consumer price index (absolute), 2011-15
Table 22: South Africa exchange rate, 2011-15

List of Figures
Figure 1: South Africa generics market value: $ million, 2011-15(e)
Figure 2: South Africa generics market volume: % of total pharma volume, 2011-15(e)
Figure 3: South Africa generics market geography segmentation: % share, by value, 2015(e)
Figure 4: South Africa generics market value forecast: $ million, 2015-20
Figure 5: South Africa generics market volume forecast: % of total pharma volume, 2015-20
Figure 6: Forces driving competition in the generics market in South Africa, 2015
Figure 7: Drivers of buyer power in the generics market in South Africa, 2015
Figure 8: Drivers of supplier power in the generics market in South Africa, 2015
Figure 9: Factors influencing the likelihood of new entrants in the generics market in South Africa, 2015
Figure 10: Factors influencing the threat of substitutes in the generics market in South Africa, 2015
Figure 11: Drivers of degree of rivalry in the generics market in South Africa, 2015
Figure 12: Adcock Ingram Holdings Limited: revenues and profitability
Figure 13: Adcock Ingram Holdings Limited: assets and liabilities
Figure 14: Aspen Pharmacare Holdings Ltd: revenues and profitability
Figure 15: Aspen Pharmacare Holdings Ltd: assets and liabilities
Figure 16: Teva Pharmaceutical Industries Limited: revenues and profitability
Figure 17: Teva Pharmaceutical Industries Limited: assets and liabilities
Adcock Ingram Holdings Limited, Aspen Pharmacare Holdings Ltd, Teva Pharmaceutical Industries Limited

Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]


2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal


3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at cs@marketinforesearch.com.

CUSTOMERS WHO VIEWED THIS REPORT ALSO VIEWED

There are no reports matching the selection.

Browse similar reports by category:
Pharmaceuticals & Healthcare
MarketLine

Our Clients